Why the study?
Is endothelium-dependent vasodilatation impaired in peritoneal dialysis patients compared to controls?
Is endothelium-dependent vasodilatation impaired in peritoneal dialysis patients compared to controls?
Answers are grounded in this paper and cite their sources.
Chronic peritoneal dialysis patients exhibit impaired endothelium-dependent vasodilatation, which may contribute to their increased susceptibility to atherosclerosis and thrombosis.
BACKGROUND: Peritoneal dialysis (PD) patients have a high risk of cardiovascular mortality, which is not completely explained by conventional risk factors. Other factors related to chronic renal failure and/or dialysis treatment might lead to endothelial dysfunction, which is associated with an adverse cardiovascular outcome. One such factor is hyperhomocysteinaemia, which has a high prevalence in PD patients. METHODS: A vessel wall movement detector system was used to investigate endothelium-dependent, flow-mediated, and endothelium-independent, glyceryl trinitrate-induced, vasodilatation of the brachial artery in 29 PD patients and 29 control subjects. RESULTS: Endothelium-dependent vasodilatation was markedly reduced in the PD group: 5.7 +/- 1.0% vs 10.4 +/- 1.3% in the control group (P = 0.004). Endothelium-independent vasodilatation was not impaired. Plasma total homocysteine was elevated in the PD patients (45.2 +/- 6.2 micromol/l), but was not related to endothelium-dependent vasodilatation. CONCLUSION: Chronic peritoneal dialysis patients have impaired endothelium-dependent vasodilatation, which may reflect an increased susceptibility for the development of atherosclerosis and thrombosis.
No takes yet. Share an insight, caveat, or question.
Coen van Guldener (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: